FirstPharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FirstPharma
Largest movements
- Receivables within one year -€127,762
down €127,762 (-76.5%), from €167,024 to €39,262
of which Other amounts receivable: -€85,265
- Cash +€46,914
up €46,914 (+122.8%), from €38,216 to €85,130
mainly Receivables within one year (+€127,762) and Net result for the year (+€8,450)
- Trade debts -€83,186
down €83,186 (-53.0%), from €157,021 to €73,835
- Reserves +€28,575
up €28,575 (+223.4%), from €12,792 to €41,367
of which Distributable reserves: +€28,575
- Profit (loss) carried forward -€20,125
no longer reported in 2025 (was €20,125)
- Short-term financial debts -€8,452
no longer reported in 2025 (was €8,452)
- Gross operating margin +€15,339
up €15,339 (+9527.3%), from €161 to €15,500
- Taxes +€955
up €955 (+95500.0%), from €1 to €956
- Financial charges -€431
down €431 (-85.2%), from €506 to €75
- Other operating charges +€376
up €376 (+6.7%), from €5,648 to €6,024
- Financial income -€185
down €185 (-97.4%), from €190 to €5
of which Non-recurring financial income: -€190
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €205,240 | €124,392 | -€80,848 | -39.4% |
| Current assets | 29/58 | €205,240 | €124,392 | -€80,848 | -39.4% |
| Amounts receivable within one year | 40/41 | €167,024 | €39,262 | -€127,762 | -76.5% |
| Trade receivables | 40 | €68,634 | €26,137 | -€42,497 | -61.9% |
| Other amounts receivable | 41 | €98,390 | €13,125 | -€85,265 | -86.7% |
| Cash at bank and in hand | 54/58 | €38,216 | €85,130 | +€46,914 | +122.8% |
| Total equity and liabilities | 10/49 | €205,240 | €124,392 | -€80,848 | -39.4% |
| Equity | 10/15 | €39,767 | €48,217 | +€8,450 | +21.2% |
| Contributions | 10/11 | €6,850 | €6,850 | = | 0.0% |
| Reserves | 13 | €12,792 | €41,367 | +€28,575 | +223.4% |
| Non-distributable reserves | 130/1 | €2,000 | €2,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €2,000 | €2,000 | = | 0.0% |
| Distributable reserves | 133 | €10,792 | €39,367 | +€28,575 | +264.8% |
| Profit (loss) carried forward | 14 | €20,125 | - | -€20,125 | |
| Amounts payable | 17/49 | €165,473 | €76,175 | -€89,298 | -54.0% |
| Amounts payable within one year | 42/48 | €165,473 | €74,791 | -€90,682 | -54.8% |
| Financial debts | 43 | €8,452 | - | -€8,452 | |
| Credit institutions | 430/8 | €8,452 | - | -€8,452 | |
| Trade debts | 44 | €157,021 | €73,835 | -€83,186 | -53.0% |
| Suppliers | 440/4 | €157,021 | €73,835 | -€83,186 | -53.0% |
| Taxes, remuneration and social security | 45 | - | €956 | +€956 | |
| Taxes | 450/3 | - | €956 | +€956 | |
| Accrued charges and deferred income | 492/3 | - | €1,384 | +€1,384 | |
| Other operating charges | 640/8 | €5,648 | €6,024 | +€376 | +6.7% |
| Non-recurring operating charges | 66A | €18 | - | -€18 | |
| Gross operating margin | 9900 | €161 | €15,500 | +€15,339 | +9527.3% |
| Operating profit (loss) | 9901 | -€5,505 | €9,476 | +€14,981 | |
| Financial income | 75/76B | €190 | €5 | -€185 | -97.4% |
| Recurring financial income | 75 | €190 | €5 | -€185 | -97.4% |
| Non-recurring financial income | 76B | €190 | - | -€190 | |
| Financial charges | 65/66B | €506 | €75 | -€431 | -85.2% |
| Recurring financial charges | 65 | €506 | €75 | -€431 | -85.2% |
| Profit (loss) for the period before taxes | 9903 | -€5,821 | €9,406 | +€15,227 | |
| Income taxes | 67/77 | €1 | €956 | +€955 | +95500.0% |
| Profit (loss) for the period | 9904 | -€5,822 | €8,450 | +€14,272 | |
| Profit (loss) for the period to be appropriated | 9905 | -€5,822 | €8,450 | +€14,272 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.